A Phase I Study to Evaluate Safety and Efficacy of BPI-7711 in EGFRm+/T790M+advanced or Recurrent NSCLC Patients
Annals of Oncology（2019）
Key words
EGFR-TKI,NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined